Roles and Clinical Applications of OPG and TRAIL as Biomarkers in Cardiovascular Disease
Joint Authors
Bernardi, Stella
Fabris, Bruno
Toffoli, Barbara
Bossi, Fleur
Source
Issue
Vol. 2016, Issue 2016 (31 Dec. 2016), pp.1-12, 12 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2016-04-21
Country of Publication
Egypt
No. of Pages
12
Main Subjects
Abstract EN
Cardiovascular diseases (CVD) remain the major cause of death and premature disability in Western societies.
Assessing the risk of CVD is an important aspect in clinical decision-making.
Among the growing number of molecules that are studied for their potential utility as CVD biomarkers, a lot of attention has been focused on osteoprotegerin (OPG) and its ligands, which are receptor activator of nuclear factor κB ligand (RANKL) and TNF-related apoptosis-inducing ligand.
Based on the existing literature and on our experience in this field, here we review what the possible roles of OPG and TRAIL in CVD are and their potential utility as CVD biomarkers.
American Psychological Association (APA)
Bernardi, Stella& Bossi, Fleur& Toffoli, Barbara& Fabris, Bruno. 2016. Roles and Clinical Applications of OPG and TRAIL as Biomarkers in Cardiovascular Disease. BioMed Research International،Vol. 2016, no. 2016, pp.1-12.
https://search.emarefa.net/detail/BIM-1096957
Modern Language Association (MLA)
Bernardi, Stella…[et al.]. Roles and Clinical Applications of OPG and TRAIL as Biomarkers in Cardiovascular Disease. BioMed Research International No. 2016 (2016), pp.1-12.
https://search.emarefa.net/detail/BIM-1096957
American Medical Association (AMA)
Bernardi, Stella& Bossi, Fleur& Toffoli, Barbara& Fabris, Bruno. Roles and Clinical Applications of OPG and TRAIL as Biomarkers in Cardiovascular Disease. BioMed Research International. 2016. Vol. 2016, no. 2016, pp.1-12.
https://search.emarefa.net/detail/BIM-1096957
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1096957